Centene Corporation

Case Overview
45 Days Left to Seek Lead Plaintiff
Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 09/08/2025 |
Status: | Status: Investigating |
Company Name: | Company Name: Centene Corporation |
Case Number: | Case Number: 1:25cv05659 |
Class Period: | Class Period: 12/12/2024 - 06/30/2025 |
Ticker: | Ticker: CNC |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Centene Corporation (“Centene” or the “Company”) (NYSE:CNC) securities during the period of December 12, 2024 through June 30, 2025, inclusive (“the Class Period”). Investors have until September 8, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
On July 1, 2025, Centene issued a press release withdrawing 2025 guidance. Particularly, following an analysis of the 2025 Health Insurance Marketplace, Centene's overall market growth across 22 states, or 72% of the Company's marketplace membership, was lower than expected. Centene stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75. On this news, the price of Centene's shares declined by approximately 40.4%, from a closing price of $56.65 per share on July 1, 2025 to close at $33.78 per share on July 2, 2025.
According to the complaint, Centene provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates.
On July 1, 2025, Centene issued a press release withdrawing 2025 guidance. Particularly, following an analysis of the 2025 Health Insurance Marketplace, Centene's overall market growth across 22 states, or 72% of the Company's marketplace membership, was lower than expected. Centene stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75. On this news, the price of Centene's shares declined by approximately 40.4%, from a closing price of $56.65 per share on July 1, 2025 to close at $33.78 per share on July 2, 2025.